Lighthouse Pharmaceuticals, Inc.
🇺🇸United States
Study of LHP588 in Subjects with P. Gingivalis-Positive Alzheimer's Disease
Phase 2
Recruiting
- Conditions
- Alzheimer DiseaseAlzheimer Disease Due to P. Gingivalis
- Interventions
- Drug: Placebo Drug
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06847321
- Locations
- 🇺🇸
Northwest Clinical Research Center, Bellevue, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath